Upregulation of vascular renin-angiotensin and endothelin systems in rats inhibited of nitric oxide synthesis

Pharmacological Research

Volumn 46, Issue 5, 2002, Pages 383-387

  Lee, Jongun ^a,b   Kim, Sunmi ^a   Oh, Yoonwha ^a   Ryu, Sun Youl ^a   Kim, Soo Wan ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Endothelin system; NG nitro L arginine methyl ester; Neutral endopeptidase; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; RENIN; ENDOTHELIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; ENDOTHELIN-1; GENE EXPRESSION; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 0036433089     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043661802001731     Document Type: Article

References (25)

1. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 1992; 20: 298-303.
2. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993; 21: 660-6.
3. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993; 21: 944-8.
4. Navarro J, Sanchez A, Saiz J, Ruilope LM, Garcia-Estan J, Romero JC, Moncada S, Lahera V. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994; 267: R1516-21.
5. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol 1995; 6: 1476-81.
6. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 1995; 91: 771-5.
7. Gonzalez W, Soleilhac JM, Fournie-Zaluski MC, Roques BP, Michel JB. Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels. Eur J Pharmacol 1998; 345: 323-31.
8. Gafford JT, Skidgel RA, Erdos EG, Hersh LB. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983; 22: 3265-71.
9. Abassi Z, Golomb E, Keiser HR. Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin. Metabolism 1992; 41: 683-5.
10. Tank JE, Moe OW, Henrich WL. Abnormal regulation of proximal tubule renin mRNA in the Dahl/Rapp salt-sensitive rat. Kidney Int 1998; 54: 1608-16.
11. Passier RC, Smits JF, Verluyten MJ, Studer R, Drexler H, Daemen MJ. Activation of angiotensin converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995; 269: H1268-76.
12. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 1992; 188: 446-52.
13. Abassi Z, Gurbanov K, Rubinstein I, Better OS, Hoffman A, Winaver J. Regulation of intrarenal blood flow in experimental heart failure: Role of endothelin and nitric oxide. Am J Physiol 1998; 274: F766-74.
14. Malfroy B, Schofield PR, Kuang WJ, Seeburg PH, Mason AJ, Henzel WJ. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem Biophys Res Commun 1987; 144: 59-66.
15. Mistry SK, Chatterjee PK, Weerackody RP, Hawksworth GM, Knott RM, McLay JS. Evidence for atrial natriuretic factor induced natriuretic peptide receptor subtype switching in rat proximal tubular cells during cell culture. Exp Nephrol 1998; 6: 101-11.
16. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997; 99: 278-87.
17. Kashiwagi M, Shinozaki M, Hirakata H, Tamaki K, Hirano T, Tokumoto M, Goto H, Okuda S, Fujishima M. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol 2000; 11: 616-24.
18. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998; 31: 342-8.
19. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 1995; 91: 771-5.
20. D'Amours M, Lebel M, Grose JH, Lariviere R. Renal and vascular effects of chronic nitric oxide synthase inhibition: Involvement of endothelin 1 and angiotensin II. Can J Physiol Pharmacol 1999; 77: 8-16.
21. Banting JD, Friberg P, Adams MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens 1996; 14: 975-81.
22. Moreau P, Takase H, Kung CF, Shaw S, Luscher TF. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension 1997; 29: 763-9.
23. A receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade? J Cardiovasc Pharmacol 1995; 26: S462-5.
24. Ikeda M, Kohno M, Takeda T. Endothelin production in cultured mesangial cells of spontaneously hypertensive rats. Hypertension 1995; 25: 1196-201.
25. A receptors in humans? Trends Pharmacol Sci 1994; 15: 9-11.